226 related articles for article (PubMed ID: 4027899)
1. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
[TBL] [Abstract][Full Text] [Related]
2. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
Xue J
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of cytofluorometry in bladder tumors].
Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
6. RNA and DNA content of isolated nuclei from bladder irrigation specimens as measured by flow cytometry.
Staiano-Coico L; Wolf R; Darzynkiewicz Z; Whitmore WF; Melamed MR
Anal Quant Cytol; 1984 Mar; 6(1):24-9. PubMed ID: 6203451
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
8. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
[TBL] [Abstract][Full Text] [Related]
9. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
[TBL] [Abstract][Full Text] [Related]
10. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
Jakobsen A; Mommsen S; Olsen S
Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
[TBL] [Abstract][Full Text] [Related]
11. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. Comparison of different isolation methods and relation to histological grade and stage.
Malmström PU; Vasko J; Wester K; Norlén BJ; Busch C
APMIS; 1989 Sep; 97(9):811-9. PubMed ID: 2506919
[TBL] [Abstract][Full Text] [Related]
13. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder.
Norming U; Nyman CR; Tribukait B
J Urol; 1989 Dec; 142(6):1442-7. PubMed ID: 2585616
[TBL] [Abstract][Full Text] [Related]
14. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of primary and metastatic bladder cancer.
Badalament RA; O'Toole RV; Keyhani-Rofagha S; Barkley C; Kenworthy P; Accetta P; Wise H; Perez JF; Drago JR
J Urol; 1990 May; 143(5):912-5; discussion 915-6. PubMed ID: 2329605
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tissue disaggregation techniques of transitional cell bladder carcinomas for flow cytometry and chromosomal analysis.
Smeets AW; Pauwels RP; Beck HL; Feitz WF; Geraedts JP; Debruyne FM; Laarakkers L; Vooijs GP; Ramaekers FC
Cytometry; 1987 Jan; 8(1):14-9. PubMed ID: 3026756
[TBL] [Abstract][Full Text] [Related]
17. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
Yu DS; Hsu CM; Chang SY; Ma CP
J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma.
Acar H; Kilinç M; Yildirim MS; Kaynak M; Cenker A
Cancer Genet Cytogenet; 2003 Apr; 142(1):25-9. PubMed ID: 12660029
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
Malmström PU
Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
[TBL] [Abstract][Full Text] [Related]
20. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
Fradet Y; Tardif M; Bourget L; Robert J
Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
